Funding
← Back to your selection

Dynagrow Capital

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$9.5M
1 disclosed · full round size, not this investor’s share

By stage

Series B1

By primary sector

Biotech1

By country

United States1

Rounds

1 in this selection
Astrocyte Pharmaceuticals Inc.

Astrocyte Pharmaceuticals develops treatments intended to protect brain tissue after concussion, traumatic brain injury and stroke by targeting astrocytes.

$9.5MSeries B
Participant